Home

Betöltés gazdagítás malom teva newss Igazán Gazdasági Erős szél

Teva News - Latest teva News, Information & Updates - Health News -ET  HealthWorld
Teva News - Latest teva News, Information & Updates - Health News -ET HealthWorld

Teva to settle opioid-related claims in Florida for $117 million | The  Times of Israel
Teva to settle opioid-related claims in Florida for $117 million | The Times of Israel

Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury  finds - JURIST - News
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News

Teva Pharmaceuticals USA - News, Articles etc. - European Pharmaceutical  Review
Teva Pharmaceuticals USA - News, Articles etc. - European Pharmaceutical Review

Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics take  their toll | Fierce Pharma
Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics take their toll | Fierce Pharma

Generic drugmakers Teva and Sandoz make major push to biosimilars | Reuters
Generic drugmakers Teva and Sandoz make major push to biosimilars | Reuters

Teva shares surge after announcing global opioid settlement
Teva shares surge after announcing global opioid settlement

Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters

Teva Tries to Put an End to the Opioid Wars - WSJ
Teva Tries to Put an End to the Opioid Wars - WSJ

Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement -  Bloomberg
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg

After turbulent years, Teva CEO Schultz forecasts stability - Israel News -  The Jerusalem Post
After turbulent years, Teva CEO Schultz forecasts stability - Israel News - The Jerusalem Post

Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to  hold shareholder vote
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote

Teva shares plunge as competitors get nod for copycat flagship drug | The  Times of Israel
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel

Teva Pharmaceuticals Lays Off Half Its Israeli Workers
Teva Pharmaceuticals Lays Off Half Its Israeli Workers

Teva Settles Arkansas Price-Fixing Case for $931K | Arkansas Business News  | ArkansasBusiness.com
Teva Settles Arkansas Price-Fixing Case for $931K | Arkansas Business News | ArkansasBusiness.com

Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva Pharmaceutical's Sales Slump 18% - WSJ

Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News

Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz -  YouTube
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube

Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked  Bond Tied to Both Climate and Access to Medicine Targets | News Direct
Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets | News Direct

Teva Pharmaceuticals to pay New York $523 million to settle claims from its  role in opioids crisis - ABC News
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News

Teva, with a $4.25B opioid settlement in hand, eyes return to growth by  2027 | Fierce Pharma
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma

Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of  Israel
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel

Teva to acquire Allergan for $40B
Teva to acquire Allergan for $40B

Teva Pharmaceuticals to Pay $225M to Texas to Settle Opioid Epidemic Claims  - Top Class Actions
Teva Pharmaceuticals to Pay $225M to Texas to Settle Opioid Epidemic Claims - Top Class Actions

In The News: Teva, Superfeet, Red Wing - Footwear Insight
In The News: Teva, Superfeet, Red Wing - Footwear Insight